Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01713938

Ligand	Ligand name	Chain	PDB	Tanimoto
VRG	N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithyl-N-methyl-L-phenylalanyl-L-aspartic acid	A,B	3CHE	0.71
MKC	6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL	A	1RT1	0.8
MY5	{1-[(3S)-4-{[(1S)-2-(BENZYLAMINO)-1-METHYL-2-OXOETHYL]AMINO}-3-HYDROXY-4-OXOBUTANOYL]HYDRAZINO}ACETIC ACID	I	2CNN	0.71
WRG	N~2~-acetyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithyl-N-methyl-L-phenylalanine	A,B	3CHD	0.71
50U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	A	2ZDK	0.71
50U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	H,I	2ZG0	0.71
PLH	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	A	1HFC	0.7
PLH	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	A	1MNC	0.7
Y14	N-[(1S)-2-{[(3S)-1-benzyl-3-cyanopyrrolidin-3-yl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	A,B	2R9N	0.73
32U	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	H,I	2ZDA	0.7
KHA	1-(4-{[(2-HYDROXYETHYL)AMINO]CARBONYL}BENZYL)-1-METHYLPIPERIDINIUM	H,L,X,Y	1UWG	0.72
FAF	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	B,C	1GGD	0.72
5FH	(5S)-5-benzylimidazolidine-2,4-dione	A	2JLO	0.73
998	N-METHYLALANYL-3-METHYLVALYL-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE	A	1TFQ	0.7
TFK	3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE	A	1EAS	0.74
26U	N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide	H,I	2ZIQ	0.71
FA4	SM-25453	A,B	2D1O	0.71
FA4	SM-25453	A,B	2D1N	0.71
DI2	AC-(D)PHE-PRO-BOROLYS-OH	H	1LHD	0.72
10U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	A	2ZFT	0.71
10U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	H,I	3BIU	0.71
49U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	A	2ZDN	0.72
49U	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	H,I	2ZHF	0.72
MIN	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	H,I	1TOM	0.72
DP7	AC-(D)PHE-PRO-BOROARG-OH	H	1LHC	0.72
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1JLA	0.71
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1RT2	0.71
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1S1V	0.71
53U	D-phenylalanyl-N-benzyl-L-prolinamide	H,I	2ZFF	0.74
DI5	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	H	1LHG	0.73
DI4	AC-(D)PHE-PRO-BOROHOMOLYS-OH	H	1LHF	0.72
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SN9	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1SNE	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SNA	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1XOF	0.71
VBP	4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid	B,E,G,H,J,L,N,P	3H06	0.72
X22	(3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}-N-(diphenylmethyl)-7-(hydroxymethyl)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide	A,B,C,D	3CLX	0.72
X22	(3S,6S,7S,9aS)-6-{[(2S)-2-aminobutanoyl]amino}-N-(diphenylmethyl)-7-(hydroxymethyl)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide	A,B,C,D	3CM7	0.72
UBC	(S)-1-(2-AMINO-2-CARBOXYETHYL)-3-(2-CARBOXYBENZYL)PYRIMIDINE-2,4-DIONE	A,B	2F35	0.71
11U	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	H,I	3BIV	0.71
DFK	D-PHENYLALANYL-N-[(1S)-4-{[(Z)-AMINO(IMINO)METHYL]AMINO}-1-(CHLOROACETYL)BUTYL]-L-PROLINAMIDE	H,L	3E6P	0.71
FCK	3-({[3-({[(1E)-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methylidene]amino}oxy)propyl]amino}methyl)benzoic acid	B	3FCK	0.71
BBT	2-HYDROXY-5-[4-(2-HYDROXY-ETHYL)-PIPERIDIN-1-YL]-5-PHENYL-1H-PYRIMIDINE-4,6-DIONE	A	1JJ9	0.73
UNH	({1-[1-CARBAMOYL-PHENYL-METHYL)-CARBAMOYL]-METHYL}-AMINOOXALYL)-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL)-CYCLOHEXYL-METHYL)-CARBAMIC ACID ISOBUTYL ESTER	A,C	2A4G	0.71
GCA	6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL	A	1C1B	0.78
A70	N-ethyl-N-[(4-methylpiperazin-1-yl)carbonyl]-D-phenylalanyl-N-[(1S,2S,4R)-4-(butylcarbamoyl)-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]-L-norleucinamide	A	1ZAP	0.7
24U	1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	H,I	2ZI2	0.7
AIP	ANTIPAIN	A,B	1BCR	0.7
BAV	(3S,14R,16S)-16-[(1R)-1-hydroxy-2-{[3-(1-methylethyl)benzyl]amino}ethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione	A,B,C	3DV5	0.73
31U	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	H,I	2ZNK	0.71
TTX	TENTOXIN	B	1KMH	0.75
URG	N-acetyl-D-alanyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]-L-ornithyl-N-methyl-L-phenylalanyl-L-aspartic acid	A,B	3CHF	0.7
BAU	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	A,B,C,D,E,F	1U1C	0.79
BAU	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	A,B,C,D	3EUF	0.79
SOS	[(1R,2S,4R)-4-({2-AMINO-5-[BENZYL(FORMYL)AMINO]-6-OXO-1,6-DIHYDROPYRIMIDIN-4-YL}AMINO)-2-HYDROXYCYCLOPENTYL]METHYL DIHYDROGEN PHOSPHATE	A,B	3C58	0.78
BAG	N-[(E)-2-AMINO-1-(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)-2-HYDROXYVINYL]BENZAMIDE	A	1WDA	0.72
37U	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	H,I	2ZDV	0.72
27U	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	H,I	2ZHQ	0.7
MEL	[((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID	H,I	1K22	0.71
MEL	[((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID	A	1K1P	0.71
51U	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	H,I	2ZF0	0.72
29U	1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide	H,I	2ZGX	0.7
3FL	3-{[(4-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]amino}butyl)amino]methyl}benzoic acid	A,B	3FCL	0.73